News

Vertex Pharmaceuticals (NasdaqGS:VRTX) has agreed to acquire Crinetics Pharmaceuticals in a deal expected to close in the third quarter of 2026. The transaction is designed to broaden Vertex's reach in biotech and add new disease areas beyond its core cystic fibrosis franchise. Investors are watching for the potential impact on Vertex's drug pipeline and competitive position as the companies work toward closing. Vertex Pharmaceuticals enters this deal with a sizeable track record in cystic...

(Bloomberg) -- Wall Street’s appetite for weight-loss drug stocks over the past four years has powered Eli Lilly & Co. to consistently trade above $1,000 per share. Now, some see the pharma giant’s stock as primed for a split.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundS&P 5

Aug 4 () - Pfizer on Tuesday slightly raised the lower end of ‌its full-year revenue forecast after ‌beating Wall Street estimates for second-quarter profit, driven ​by strong demand for blood thinner Eliquis. Pfizer is banking on newer medicines to offset ‌fading COVID revenue ⁠and reduce reliance on aging blockbuster drugs, while investors look ⁠for signs that its $10 billion purchase of Metsera can help establish a meaningful ​presence in ​the fast-growing ​obesity market.

(Bloomberg) -- Caterpillar Inc. posted second-quarter earnings and revenue that beat Wall Street expectations as the company’s power-generation business continued to post strong growth off the back of data center spending.Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevApple’s New CEO Taps Retired Hardware Executive for Management TeamTaco Bell Met With Michigan on Parasite Weeks Before RecallMamdani Dismisses Business Leaders Advising NYC’s Mayor’s FundS&P 500 C

September Nasdaq 100 E-Mini futures (NQU26) are up +0.67% this morning, signaling further gains for tech stocks as blockbuster earnings from Palantir Technologies boosted sentiment.

Several AI stocks are on sale.

Defense contractor Leidos (NYSE:LDOS) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.2% year on year to $4.56 billion. The company expects the full year’s revenue to be around $18.3 billion, close to analysts’ estimates. Its non-GAAP profit of $3.26 per share was 12.1% above analysts’ consensus estimates.

ON Semiconductor (NASDAQ:ON) shares climbed 7. 6% in pre-market trading after the chipmaker reported second-quarter 2026 results that exceeded Wall Street forecasts and issued a stronger-than-expected outlook for the current quarter.

Palantir Technologies (NASDAQ:PLTR) shares surged 16. 1% in pre-market trading after the artificial intelligence and data analytics company reported record second-quarter 2026 results that comfortably surpassed Wall Street expectations.

Oracle (NYSE:ORCL) shares rallied 9. 22% on Monday, August 3, extending their recent recovery and lifting the stock’s gain over the past week to 18.

In July 2026, Freeport-McMoRan reported second-quarter 2026 results showing higher net income and earnings per share year over year, alongside broadly steady sales, and updated guidance forecasting significantly higher copper and gold sales in the second half of 2026 and into 2027. The company also continued its share repurchase program, having bought back 55,374,242 shares for US$2.20 billion since late 2021, which reduces the share count and may enhance per-share metrics over time. Next,...

Wix. com (NASDAQ:WIX) shares climbed 3.

The South Korean company is the “memory leader for the AI era,” William Blair analyst Sebastien Naji says.

Druckenmiller said he sees "massive disruption" ahead for the chip industry.

Markets are coming off a Big Tech rally, eyeing uncertainty in Middle East talks and SpaceX earnings after the bell.

The Swedish audio streamer reported a 14% quarterly revenue increase from a year earlier.

Spotify Technology reached a milestone of 300 million premium subscribers in the second quarter while growing revenue by 14% in the period compared with a year earlier. Spotify added seven million premium subscribers in the second quarter, bringing its total to 300 million and beating the company’s prior guidance by one million. The Swedish audio streamer’s monthly active users grew by 12% year-over-year to 777 million, falling short of the company’s prior guidance by one million.

Sandisk's share price has fallen dramatically from its June highs, even as its business remains strong.

With increased AI infrastructure spending, Nvidia, SK Hynix, and TSMC all look like good buys.

CTXAY, PICS, SLDE, AMD and RS have been added to the Zacks Rank #1 (Strong Buy) List on August 4th, 2026.

They all complement each other well, covering a lot of ground for investors.

Almonty Industries Inc. (ALM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

SANM, NVDA and PENN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4th, 2026.

Both Microsoft and Amazon are coming off terrific earnings reports.

Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. The flip side is that they frequently fall behind growth industries when times are good, and this perception became a reality over the past six months as the sector was down 5.7% while the S&P 500 was up 8.3%.

Crinetics Pharmaceuticals stock has delivered very strong gains over the past few years, yet the current valuation checks point to a market price that leans expensive rather than clearly cheap. Crinetics Pharmaceuticals has returned about 384% over the past 3 years, which puts recent enthusiasm for the stock firmly in focus for anyone thinking about upside from here. Vertex Pharmaceuticals' agreement to acquire Crinetics and the regulatory progress for atumelnant can support high...

IMAX, AMC, and Cinemark stocks climbed as blockbuster movies filled theaters, while Netflix stock declined.

South Korean retail shareholder platform ACT said on Tuesday it had launched a campaign to call an extraordinary ‌shareholders' meeting at Samsung Electronics, urging the chipmaker to buy back about $32 ‌billion worth of shares and set limits on performance bonuses. ACT said it would begin collecting electronic ​signatures from shareholders at 5 p.m. local time and seek support from the National Pension Service and domestic and overseas asset managers to meet the 3% ownership threshold required to call the meeting. The move comes after Samsung shares lost over ‌one third of their value ⁠since hitting record-highs in June, despite the artificial intelligence boom.

Stocks looked set to rise again on Tuesday as Palantir’s stellar earnings helped breathe some life back into the artificial-intelligence trade. Nasdaq 100 futures rose 0.8%. S&P 500 futures climbed 0.

Retail traders remain wary. Sentiment on Stocktwits shows they remain ‘bearish’ on SPY and QQQ.